← 產業報告目錄
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-01頁數 175報告編號 INSIGHTACE-779d947a5a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 1.53 billion, the global Latent Tuberculosis Infection Detection Market is expected to advance to USD 2.37 billion by 2031, demonstrating a CAGR of 5.7% during the 2024–2031 forecast window.
At its core, Latent Tuberculosis Infection Detection pertains to a critical component of tuberculosis (tb) control, aiming to prevent the progression to active tb disease. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Latent Tuberculosis Infection Detection Market Snapshot
Chapter 4. Global Latent Tuberculosis Infection Detection Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Brand Estimates & Trend Analysis
5.1. by Brand & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Brand:
5.2.1. QFT-Plus (QuantiFERON-TB Gold Plus)
5.2.2. Others
Chapter 6. Market Segmentation 2: by Test Type Estimates & Trend Analysis
6.1. by Test Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Test Type:
6.2.1. Tuberculin Skin Test (TST)
6.2.2. Interferon Gamma Released Assay (IGRA)
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Household Contacts with Pulmonary TB
7.2.2. PLHIV
7.2.3. Other
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
8.2.1. Diagnostic Laboratories
8.2.2. Hospitals/Clinics
8.2.3. Academic & Research Institutions
Chapter 9. Latent Tuberculosis Infection Detection Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Brand, 2024-2031
9.1.2. North America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
9.1.3. North America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.4. North America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.1.5. North America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Brand, 2024-2031
9.2.2. Europe Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
9.2.3. Europe Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.4. Europe Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.2.5. Europe Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Brand, 2024-2031
9.3.2. Asia Pacific Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
9.3.3. Asia-Pacific Thermal Cyclers Asia-Pacific Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.4. Asia-Pacific Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.3.5. Asia Pacific Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Brand, 2024-2031
9.4.2. Latin America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
9.4.3. Latin America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.4. Latin America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.4.5. Latin America Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Brand, 2024-2031
9.5.2. Middle East & Africa Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
9.5.3. Middle East & Africa Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.4. Middle East & Africa Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.5.5. Middle East & Africa Latent Tuberculosis Infection Detection Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. QIAGEN
10.2.2. BIOMÉRIEUX
10.2.3. Oxford Immunotec
10.2.4. SD Biosensor, INC.
10.2.5. Wantai BioPharm
10.2.6. Lionex GmbH
10.2.7. Sanofi
10.2.8. Serum Institute of India Pvt. Ltd
10.2.9. ARKRAY, Inc.
10.2.10. Par Pharmaceutical, Inc.
10.2.11. Abbott,
10.2.12. F. Hoffmann-La Roche Ltd,
10.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們